![Melissa Starovasnik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa Starovasnik
Directeur/Bestuurslid bij TWIST BIOSCIENCE CORPORATION
Vermogen: 718 795 $ op 31-05-2024
Profiel
Melissa A.
Starovasnik is an Independent Director at Twist Bioscience Corp.
She previously worked as Vice President-Protein Sciences at Genentech, Inc. from 2011 to 2017.
She received her undergraduate degree in 1987 and her doctorate in 1992 from the University of Washington.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TWIST BIOSCIENCE CORP.
0.03% | 06-02-2024 | 17 155 ( 0.03% ) | 718 795 $ | 31-05-2024 |
Actieve functies van Melissa Starovasnik
Bedrijven | Functie | Begin |
---|---|---|
TWIST BIOSCIENCE CORPORATION | Directeur/Bestuurslid | 06-08-2021 |
Eerdere bekende functies van Melissa Starovasnik
Bedrijven | Functie | Einde |
---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Melissa Starovasnik
University of Washington | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TWIST BIOSCIENCE CORPORATION | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |